Expression-based Pathway Signature Analysis (EPSA): Mining Microarray Data for Human Disease Insights
Author Information
Author(s): Jessica D Tenenbaum, Michael G Walker, Paul J Utz, Atul J Butte
Primary Institution: Stanford University School of Medicine
Hypothesis
Can publicly available microarray data be reused to generate insights into human disease?
Conclusion
EPSA allows for the identification of potential pathways of dysregulation in human disease and leads for therapeutic targets.
Supporting Evidence
- EPSA can be applied to various datasets despite differences in platforms and experimental designs.
- EPSA demonstrated a high level of accuracy in identifying underlying mutations in cancer data.
- Survival analysis showed that pathway activation is a significant factor for patient prognosis.
Takeaway
The study created a new method to analyze existing data about diseases, helping to find new ways to understand and treat illnesses.
Methodology
The study used a statistical method to compare gene expression patterns in human diseases with those from known perturbations in microarray datasets.
Potential Biases
Potential biases may arise from the underutilization of datasets and the assumptions made during data integration.
Limitations
The method may not account for all biological variability and relies on the quality of existing datasets.
Participant Demographics
The study involved 240 patients with diffuse large B cell lymphoma.
Statistical Information
P-Value
0.0004
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website